Chemo Brain in Cancer Patients: What Is It and How Can It Be Managed?

Slideshow

Many patients complain of "chemo brain," or a drop in cognitive function during or after receiving chemotherapy, but there are strategies to manage chemo brain, as well as research on how chemotherapy affects the brain long-term.

“Chemo brain” is a side effect of chemotherapy that affects cognitive function in cancer patients. Also known as cancer treatment–related cognitive impairment, it is often described as a decrease in mental “sharpness” before, during, and after cancer treatment, according to the American Cancer Society (ACS). The length of these effects, as well as their severity, vary. Although there is no test to diagnose the condition, nor specific treatment, some medications and coping strategies have been shown to be helpful in some patients. This slideshow discusses several strategies to manage chemo brain, as well as research on how chemotherapy affects the brain long-term.

Recent Videos
4 experts in this video
4 experts in this video
Ongoing research suggests environmental exposures and the role of microbiomes may influence bladder cancer development and response to treatment.
Providing easier access to ancillary services for patients with PDAC who live farther away from the treatment center may help them complete the treatment regimen.
Future research will aim to assess the efficacy of PIPAC-MMC plus systemic therapy vs systemic therapy alone in patients with peritoneal tumors.
Although small incision surgery may serve as a conduit to deliver PIPAC-MMC, it may confer benefits in the staging and treatment of peritoneal tumors.
Related Content